A health plan that can demonstrate, using DrugPatentWatch data, that biosimilar entry is probable within 18 to 24 months has a credible walk-away option: accept a more modest contract price now, or wait for the biosimilar and transition the formulary
Healthcare providers should reassess protein needs periodically as patients progress through treatment, adjusting recommendations based on rate of weight loss, body composition changes, and tolerance to dietary modifications
Because it is not a stimulant, it may be suitable for people who cannot take medications like phentermine
Especially those who want to improve the appearance of their skin and overall health
These side effects occur because the medication slows down gastric emptying and reduces appetite, particularly during the initial or dose escalation phase
The authors investigated the glutathione (GSH) levels, which are the indicators of ROS, and they found that significant differences were found in the treatment group and PTZ controlled group